Oncovet Clinical Research (OCR) is a leading brand dedicated to accelerating the development of new treatments for serious chronic diseases in both humans and pets. With a mission to address the unmet need for biotech and pharmaceutical companies to access highly predictive models of human diseases, OCR collaborates with pharmaceutical partners to design and manage cost-effective clinical trials in dogs and cats with spontaneous diseases, as well as in vitro/ex-vivo studies. By leveraging this innovative approach, OCR plays a crucial role in advancing the research and development process for new drug candidates and medical devices in various therapeutic areas, including oncology, cardiology, neurology, and inflammation.

OCR has already established partnerships with key players in the veterinary sector for pilot and pivotal clinical studies in pets, supporting the entire process from ideation to marketing authorization. As your trusted partner in Europe, OCR boasts a wide network of 50 specialized Vet Clinical Investigation Centers focused on age-related and chronic diseases in pets. With recognized experts in oncology, cardiology, internal medicine, radiology, and nephrology, OCR's clinical teams consisting of skilled veterinarians and nurses ensure the successful implementation of clinical studies on sites